Telomerase Inhibition Is an Effective Therapeutic Strategy in TERT Promoter Mutant-Glioblastoma Models with Low Tumor Volume

0
297
Researchers used CRISPR interference to knock down TERT expression in TERT promoter-mutant glioblastoma cell lines and patient-derived models. They then measured viability using serial proliferation assays.
[Neuro-Oncology]
Abstract